These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

32 related articles for article (PubMed ID: 7704566)

  • 21. Immunodominant antigenic sites in primate immunodeficiency viruses and in vivo protection.
    Norrby E; Putkonen P; Albert J; Fenyö EM
    Biotechnol Ther; 1991; 2(1-2):21-9. PubMed ID: 1668984
    [No Abstract]   [Full Text] [Related]  

  • 22. HIV type 1 vaccine-induced cytotoxic T cell responses: potential role in vaccine efficacy.
    Ada GL; McElrath MJ
    AIDS Res Hum Retroviruses; 1997 Feb; 13(3):205-10. PubMed ID: 9115805
    [No Abstract]   [Full Text] [Related]  

  • 23. Progress and challenges in therapies for AIDS in nonhuman primate models.
    Haigwood NL
    J Med Primatol; 1999; 28(4-5):154-63. PubMed ID: 10593480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Application of herpes simplex virus to HIV vaccine vector].
    Watanabe D; Knipe DM
    Nihon Rinsho; 2006 Mar; 64 Suppl 3():366-70. PubMed ID: 16615500
    [No Abstract]   [Full Text] [Related]  

  • 25. Assessment of HIV vaccine development: past, present, and future.
    Cho MW
    Adv Pharmacol; 2000; 49():263-314. PubMed ID: 11013767
    [No Abstract]   [Full Text] [Related]  

  • 26. HIV vaccines: prospects and challenges.
    Baltimore D; Heilman C
    Sci Am; 1998 Jul; 279(1):98-103. PubMed ID: 9648305
    [No Abstract]   [Full Text] [Related]  

  • 27. Mechanisms and strategies of viral antigenic variation.
    Folks TM
    Ann N Y Acad Sci; 1994 Aug; 730():37-41. PubMed ID: 8080212
    [No Abstract]   [Full Text] [Related]  

  • 28. Vaccines against HIV.
    Carmichael AJ; Sissons JG
    QJM; 1995 Feb; 88(2):77-9. PubMed ID: 7704566
    [No Abstract]   [Full Text] [Related]  

  • 29. CTL ontogeny and viral escape: implications for HIV-1 vaccine design.
    Yang OO
    Trends Immunol; 2004 Mar; 25(3):138-42. PubMed ID: 15036041
    [No Abstract]   [Full Text] [Related]  

  • 30. Humoral immunity to HIV, SIV, and SHIV.
    Haigwood NL; Zolla-Pazner S
    AIDS; 1998; 12 Suppl A():S121-32. PubMed ID: 9632993
    [No Abstract]   [Full Text] [Related]  

  • 31. Mucosal immunity, HIV transmission, and AIDS.
    Miller CJ; McGhee JR; Gardner MB
    Lab Invest; 1993 Feb; 68(2):129-45. PubMed ID: 8441249
    [No Abstract]   [Full Text] [Related]  

  • 32. Development of bivalent rgp120 vaccines to prevent HIV type 1 infection.
    Berman PW
    AIDS Res Hum Retroviruses; 1998 Oct; 14 Suppl 3():S277-89. PubMed ID: 9814956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 2.